Condition : Rheumatoid Arthritis Interventions : Drug: Baricitinib; Drug: Methotrexate; Drug: Placebo; Drug: Folic Acid Sponsors : Eli Lilly and Company; Eli Lilly and Company Recruiting - verified Se...

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: Adalimumab; Drug: Baricitinib Sponsors : Eli Lilly and Company; Eli Lilly and Company Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: Adalimumab; Drug: Baricitinib Sponsor : Eli Lilly and Company Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: Adalimumab; Drug: Baricitinib Sponsor : Eli Lilly and Company Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Biological: Mavrilimumab or golimumab alternating with placebo subcutaneous injection Sponsor : MedImmune LLC Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Methotrexate; Drug: ENIA11; Drug: Placebo Sponsor : TSH Biopharm Corporation Limited Recruiting - verified November 2013

Condition : Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee Interventions : Drug: GRT6005 Low-Dose Range; Drug: GRT6005 High-Dose Range; Drug: Placebo; Drug: Oxycodone CR Sponsors :...

Condition : Rheumatoid Arthritis Intervention : Biological: Mavrilimumab or golimumab alternating with placebo subcutaneous injection Sponsors : MedImmune LLC; MedImmune LLC Recruiting - verified Augu...

Condition : Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee Interventions : Drug: GRT6005 Low-Dose Range; Drug: GRT6005 High-Dose Range; Drug: Placebo; Drug: Oxycodone CR Sponsors :...

Condition : Rheumatoid Arthritis Interventions : Drug: sarilumab SAR153191 (REGN88); Other: placebo Sponsors : Sanofi; Sanofi; Regeneron Pharmaceuticals Recruiting - verified September 2013